BioForce Nanosciences Holdings, Inc. (BFNH)
OTCMKTS · Delayed Price · Currency is USD
0.601
0.00 (0.00%)
At close: Apr 28, 2026

BFNH Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Selling, General & Admin
0.490.490.470.490.5
Upgrade
Operating Expenses
0.490.490.470.490.5
Upgrade
Operating Income
-0.49-0.49-0.47-0.49-0.5
Upgrade
EBT Excluding Unusual Items
-0.49-0.49-0.47-0.49-0.5
Upgrade
Other Unusual Items
-0.8----
Upgrade
Pretax Income
-1.29-0.49-0.47-0.49-0.5
Upgrade
Net Income
-1.29-0.49-0.47-0.49-0.5
Upgrade
Net Income to Common
-1.29-0.49-0.47-0.49-0.5
Upgrade
Shares Outstanding (Basic)
3329292929
Upgrade
Shares Outstanding (Diluted)
3329292929
Upgrade
Shares Change (YoY)
13.44%---79.53%
Upgrade
EPS (Basic)
-0.04-0.02-0.02-0.02-0.02
Upgrade
EPS (Diluted)
-0.04-0.02-0.02-0.02-0.02
Upgrade
EBIT
-0.49-0.49-0.47-0.49-0.5
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.